951 / 1266
Dabrafenib Activity in Brain Metastases
•
Dabrafenib, at the
recommended phase 2 dose,
has activity against brain
metastases in adult patients
with melanoma
1
–
Nine of ten (90%) melanoma
patients with untreated brain
metastases showed reduction
in brain lesion size
1. Falchook GS,
et al
.
Lancet
2012;379:1893–1901.
105